Download Report

Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Persistence Market Research
Hypocalcaemia Treatment Market : Global
Industry Analysis and Forecast 2016 - 2022
Persistence Market Research
1
Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Persistence Market Research Released New Market Report on “Hypocalcaemia Treatment
Market : Global Industry Analysis and Forecast 2016 - 2022”.
Hypocalcaemia is imbalance of electrolytes which is indicated by abnormally low level of
calcium in the body. A healthy person has 8.5-10.2 mg/dL calcium level in his/her body,
however, drop in this level could possibly led to hypocalcaemia disorder. Middle aged population
needs to take 1000 mg of calcium while geriatrics population aged 65 and above should take
1500 mg of calcium per day. Hypocalcaemia is caused by hypoalbuminemia,
hyperphosphatemia, surgical effects, medication effects, hypomagnesemia, heart failure,
muscle cramps, vitamin D deficiency, alcoholism, magnesium deficiency, insufficient protein in
the blood, in the blood and many more. Neuromuscular irritability is the most common sign of
hypocalcaemia. Hypocalcaemia are mostly diagnosed by clinical suspicion and laboratory
testing. Hypoparathyroidism has a major effect on hypocalcaemia and high recurrence rate.
Interested in report: Please follow the below links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/9650
The hypocalcaemia can be caused at any age but it is commonly observed in ill patients and
patients with parathyroid surgery and with increase in the prevalence of heat related disorders in
the older population witnessing the growth of hypocalcaemia treatment market is expected to
expand at considerable CAGR during the forecasted period. Also, with increase in the
awareness among the aging population and availability of treatment creates an opportunity for
hypocalcaemia treatment market worldwide. However, the biochemical abnormality associated
with hypocalcaemia carries risks in diagnosis and treatment.
The Hypocalcaemia Treatment Market has been classified on the basis of product, application,
end use and geography.
Persistence Market Research
2
Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Hypocalcaemia Treatment Market by type:
•
Asymptomatic
•
Symptomatic
•
Prophylactic
Hypocalcaemia Treatment Market by Drug type:
•
Radiocontrast
•
Loop diuretics
•
Calcium supplements
•
Antibiotics
•
Antiepileptic drugs
•
Estrogen
•
Bisphosphonates
•
Cinacalcet
Hypocalcaemia Treatment Market by dosage forms type:
Calcium supplements
•
Parenteral preparation
•
Oral preparation
Vitamin D supplements
•
Parenteral preparation
•
Oral preparation
Persistence Market Research
3
Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Parenteral calcium supplements dosage are given to patients suffering from acute
hypocalcaemia. Whereas, in case of chronic hypocalcaemia oral calcium supplements are
administered. Medical supervision is given to avoid risk associated with parenteral
administration. With increasing demand for effective treatment of hypocalcemia, companies
need to capitalize on their resources to offer effective medications and in turn further expand
their business footprint in developing regions.
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/9650
Depending on geographic region, hypocalcaemia treatment market is segmented into seven key
regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Incidence
rate of hypocalcaemia is quite high in North America compared to other regions. North America
dominates the global hypocalcaemia treatment market followed by Europe, Asia Pacific owing to
high awareness about the treatments of hypocalcaemia in these regions. The developing
regions such as Asia Pacific, Middle East & Africa hold huge potential and is a promising market
for hypocalcaemia treatment due to significant increase in medical tourism industry.
For more info: http://www.persistencemarketresearch.com/contact-us.asp
Key players of Hypocalcaemia Treatment Market are F. Hoffman La Roche, Novo Nordisk,
Sanofi, GlaxoSmithKline (GSK), Pfizer Inc., and Ranbaxy Pharmaceuticals Ltd.
Follow us on: https://www.linkedin.com/company/persistence-market-research-&-consulting
Persistence Market Research
4
Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
The report covers exhaustive analysis on:
•
Hypocalcaemia Treatment Market Segments
•
Hypocalcaemia Treatment Market Dynamics
•
Historical Actual Market Size, 2013 - 2015
•
Hypocalcaemia Treatment Market Size & Forecast 2016 to 2022
•
Hypocalcaemia Treatment Market Current Trends/Issues/Challenges
•
Competition & Companies involved
•
Hypocalcaemia Treatment Market Drivers and Restraints
Regional analysis includes
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East and Africa
Report Highlights:
•
Shifting Industry dynamics
•
In-depth market segmentation
•
Historical, current and projected industry size
•
Recent industry trends
•
Key Competition landscape
•
Strategies of key players and product offerings
Persistence Market Research
5
Hypocalcaemia Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
•
Potential and niche segments/regions exhibiting promising growth
•
A neutral perspective towards market performance
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and
Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping
and Transportation industries. The company draws from its multi-disciplinary capabilities and
high-pedigree team of analysts to share data that precisely corresponds to clients’ business
needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States.
USA - Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Persistence Market Research
6